Overall, despite the presence of EGFR amplification in all four cases, a diagnostic molecular marker in IDH-wildtype glioblastoma and a predictor of its aggressive behavior, IDH-mutant status was the determinate factor for an epigenetics-based classification of these high-grade astrocytomas. The gene discussed is EGFR; the disease is astrocytoma (excluding glioblastoma).